These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


112 related items for PubMed ID: 2614912

  • 1. [Clinical evaluation of a combination treatment with cefbuperazone and amikacin in infections complicating with hematological disorders].
    Tanaka S, Tsuda S, Nakagawa H, Nishigaki H, Okuda T, Taniwaki M, Misawa S, Takino T, Abe T.
    Jpn J Antibiot; 1989 Dec; 42(12):2548-54. PubMed ID: 2614912
    [Abstract] [Full Text] [Related]

  • 2. [Efficacy and safety of cefbuperazone in severe infections complicating hematologic diseases Hanshin Infection Study Group].
    Kageyama T, Ohyabu H, Masaoka T, Shibata H, Nagai K, Kitani T, Horiuchi A, Kawagoe H, Yasunaga K, Yonezawa T.
    Jpn J Antibiot; 1988 Mar; 41(3):312-21. PubMed ID: 3043032
    [Abstract] [Full Text] [Related]

  • 3. [Clinical evaluation of cefbuperazone in severe infections complicated with hematological disorders].
    Mizuno H, Yamao H, Saito H, Ohno R, Hotta T, Ohnishi K, Murate T, Kagami Y, Mitomo Y, Nitta M.
    Jpn J Antibiot; 1990 Dec; 43(12):2078-86. PubMed ID: 2086822
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Clinical evaluation of combination therapy with sulbactam/cefoperazone and amikacin sulfate for infections associated with hematological disorders].
    Fukuda M, Hirashima K.
    Jpn J Antibiot; 1993 Oct; 46(10):912-7. PubMed ID: 8254893
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Clinical evaluation of combination therapy with cefpirome and amikacin for infections associated with hematological disorders].
    Fukuda M, Kobayashi Y, Endo K, Kawai N, Tominaga K, Bessho M, Hirashima K.
    Jpn J Antibiot; 1998 Apr; 51(4):298-304. PubMed ID: 9644603
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Clinical studies on effect of cefbuperazone on surgical infections].
    Kai H, Sugimachi K, Tamada R, Takenaka K, Inuzuka S, Natsuda Y, Taguchi J, Kobayashi M, Kaneko T, Mitarai Y.
    Jpn J Antibiot; 1988 Mar; 41(3):322-30. PubMed ID: 3043033
    [Abstract] [Full Text] [Related]

  • 19. [Clinical evaluation of combination therapy with cefoxitin and amikacin in complicated urinary tract infections].
    Sakashita S, Shinno Y, Asano Y, Tubo S, Imanaka K, Miyabe N, Nagamori S, Takahashi Y, Koyanagi T.
    Hinyokika Kiyo; 1986 Oct; 32(10):1547-50. PubMed ID: 3565192
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.